Gene therapy for transplantation with viral vectors--how much of the promise has been realised?

Tan, Peng H; Tan, Peck L; George, Andrew J T; Chan, Christopher L H

Tan, Peng H; Tan, Peck L; George, Andrew J T; Chan, Christopher L H.

Afiliación

Tan PH; Oxford Transplant Centre, Oxford Radcliffe Hospitals NHS Trust, Oxford University, Churchill Hospital, Old Road, Oxford, OX3 7LJ, UK. ptan@imperial.ac.uk

Expert Opin Biol Ther ; 6(8): 759-72, 2006 Aug.

Article en En | MEDLINE | ID: mdl-16856798

RESUMEN

Gene therapy holds promise in preventing the development of many diseases. One of the possible applications is the management of organ transplantation. Over the years, advances in vector development have allowed the clinical progression of this form of therapy to become more attainable. Viral vector technology has proved to be better than non-viral vectors at ferrying therapeutic genes to cells. However, many deficiencies in viral vectors hinder the full realisation of gene-based therapy in transplantation. Here, these deficiencies and their ramifications for the future of viral vector development are fully analysed. The authors propose that the slow progress of gene therapy in transplantation may be related to the deficiencies in viral vectors.

Asunto(s)

Terapia Genética/métodos; Virus/genética; Apoptosis; Técnicas de Transferencia de Gen; Vectores Genéticos; Humanos; Leucocitos/citología; Modelos Biológicos; Linfocitos T/metabolismo; Transducción Genética; Transgenes

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Virus / Terapia Genética Límite: Humans Idioma: En Revista: Expert Opin Biol Ther Asunto de la revista: BIOLOGIA / TERAPEUTICA Año: 2006 Tipo del documento: Article Pais de publicación: Reino Unido

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links